301281.SZ
科源制药
SZSE · C 制造业 · CN
CNY 43.97
−0.20%Margins
Gross margin
55.5%
EBITDA margin
18.9%
EBIT margin
10.2%
Net margin
5.3%
FCF margin
-11.9%
1.7%
Return on equity
1.3%
Return on assets
3.0%
Return on invested capital
0.26x
Asset turnover
CNY 75.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026